期刊论文详细信息
Molecular Oncology
A novel AMPK activator shows therapeutic potential in hepatocellular carcinoma by suppressing HIF1α‐mediated aerobic glycolysis
Jui‐Wen Huang1  Chih‐Lung Lin1  Ying‐Chung Jimmy Lin2  Te‐Ping Fang3  Yi‐Siang Zeng3  Fan‐Wei Yang3  Jung‐Chen Su3  Meng‐Hsuan Lee3  Hsing‐I Tseng3  Ai‐Chung Mar4 
[1] Biomedical Technology and Device Research Labs Industrial Technology Research Institute Hsinchu Taiwan;Department of Life Science and Institute of Plant Biology National Taiwan University Taipei Taiwan;Department of Pharmacy National Yang Ming Chiao Tung University Taipei Taiwan;Taiwan International Graduate Program in Molecular Medicine National Yang Ming Chiao Tung University and Academia Sinica Taipei Taiwan;
关键词: AMPK;    hepatocellular carcinoma;    HIF1α;    SCT‐1015;   
DOI  :  10.1002/1878-0261.13211
来源: DOAJ
【 摘 要 】

Hepatocellular carcinoma (HCC) is characterized by rapid growth, early vascular invasion, and high metastasis. Currently available US Food and Drug Administration (FDA)‐approved drugs show low therapeutic efficacy, limiting HCC treatment to chemotherapy. We designed and synthesized a novel small molecule, SCT‐1015, that allosterically activated adenosine monophosphate‐activated protein kinase (AMPK) to suppress the aerobic glycolysis in HCC. SCT‐1015 was shown to bind the AMPK α and β‐subunit interface, thereby exposing the kinase α domain to the upstream kinases, resulting in the increased AMPK activity. SCT‐1015 dramatically reduced HCC cell growth in vitro and tumor growth in vivo. We further found that AMPK formed protein complexes with hypoxia‐inducible factor 1‐alpha (HIF1α) and that SCT‐1015‐activated AMPK promoted hydroxylation of HIF1α (402P and 564P), resulting in HIF1α degradation by the ubiquitin‐proteasome system. With declined HIF1α abundance, many glycolysis‐related enzymes were downregulated, suppressing aerobic glycolysis, and promoting oxidative phosphorylation. These results indicated that SCT‐1015 channeled HCC cells into an unfavorable metabolic status. Overall, we reported SCT‐1015 as a direct activator of AMPK signaling that held therapeutic potential in HCC.

【 授权许可】

Unknown   

  文献评价指标  
  下载次数:0次 浏览次数:0次